EP 2701729 B1 20190522 - HEMOSTATIC COMPOSITIONS
Title (en)
HEMOSTATIC COMPOSITIONS
Title (de)
HÄMOSTATISCHE ZUSAMMENSETZUNG
Title (fr)
COMPOSITIONS HÉMOSTATIQUES
Publication
Application
Priority
- EP 11305492 A 20110427
- US 201161517973 P 20110427
- EP 2012057647 W 20120426
- EP 12717682 A 20120426
Abstract (en)
[origin: WO2012146655A1] The invention relates to a hemostatic composition in powder form comprising collagen of the fibrillar type comprising a content of fibrous collagen and/or fibrillar collagen of at least 70% by weight relative to the total weight of the collagen, and at least one monosaccharide, and optionally, at least one compound selected from coagulation factors and glycosaminoglycans. The invention further relates to a method for preparing such composition, and to a unit comprising such composition and a spraying device.
IPC 8 full level
A61K 38/48 (2006.01); A61K 9/14 (2006.01); A61K 31/726 (2006.01); A61K 38/36 (2006.01); A61K 38/39 (2006.01); A61K 47/26 (2006.01); A61L 26/00 (2006.01)
CPC (source: CN EP US)
A61K 9/0014 (2013.01 - EP); A61K 9/14 (2013.01 - US); A61K 31/726 (2013.01 - EP US); A61K 38/36 (2013.01 - EP US); A61K 38/39 (2013.01 - EP US); A61K 38/4833 (2013.01 - EP US); A61K 47/26 (2013.01 - US); A61L 24/001 (2013.01 - CN); A61L 24/0015 (2013.01 - EP); A61L 24/0094 (2013.01 - CN); A61L 24/043 (2013.01 - EP); A61L 26/0033 (2013.01 - EP US); A61M 35/003 (2013.01 - CN); A61P 7/04 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C12Y 304/21005 (2013.01 - EP US); A61L 2300/232 (2013.01 - EP); A61L 2300/254 (2013.01 - EP); A61L 2300/418 (2013.01 - EP); A61L 2400/04 (2013.01 - CN EP US)
C-Set (source: EP)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2012146655 A1 20121101; AU 2012247480 A1 20131107; AU 2012247480 B2 20160922; AU 2016277573 A1 20170112; AU 2016277573 B2 20180906; AU 2018274924 A1 20190103; AU 2018274924 B2 20201119; AU 2021200468 A1 20210225; BR 112013027567 A2 20200609; BR 112013027567 B1 20220329; BR 122021017027 B1 20220517; CA 2830659 A1 20121101; CA 2830659 C 20210216; CA 3108894 A1 20121101; CN 103635202 A 20140312; CN 103635202 B 20160928; CN 106390186 A 20170215; CN 106390186 B 20200703; CY 1122251 T1 20201125; DK 3513803 T3 20210705; EP 2701729 A1 20140305; EP 2701729 B1 20190522; EP 3513803 A1 20190724; EP 3513803 B1 20210519; EP 3922261 A1 20211215; ES 2882911 T3 20211203; JP 2014512403 A 20140522; JP 2017066150 A 20170406; JP 6050320 B2 20161221; JP 6235104 B2 20171122; PL 2701729 T3 20200131; PL 3513803 T3 20211122; RS 59243 B1 20191031; SI 2701729 T1 20190930; US 10046034 B2 20180814; US 10342856 B2 20190709; US 2014023714 A1 20140123; US 2016166655 A1 20160616; US 2017189499 A1 20170706; US 2018318403 A1 20181108; US 2019282676 A1 20190919; US 2023381288 A1 20231130; US 9283187 B2 20160315; US 9662374 B2 20170530
DOCDB simple family (application)
EP 2012057647 W 20120426; AU 2012247480 A 20120426; AU 2016277573 A 20161220; AU 2018274924 A 20181205; AU 2021200468 A 20210125; BR 112013027567 A 20120426; BR 122021017027 A 20120426; CA 2830659 A 20120426; CA 3108894 A 20120426; CN 201280031849 A 20120426; CN 201610756407 A 20120426; CY 191100862 T 20190812; DK 19162054 T 20120426; EP 12717682 A 20120426; EP 19162054 A 20120426; EP 21171023 A 20120426; ES 19162054 T 20120426; JP 2014506862 A 20120426; JP 2016228298 A 20161124; PL 12717682 T 20120426; PL 19162054 T 20120426; RS P20191094 A 20120426; SI 201231652 T 20120426; US 201214007798 A 20120426; US 201615048647 A 20160219; US 201715465408 A 20170321; US 201816035309 A 20180713; US 201916421094 A 20190523; US 202318203411 A 20230530